Skip to main content
. Author manuscript; available in PMC: 2008 Nov 3.
Published in final edited form as: Eur J Clin Pharmacol. 2006 Nov 9;63(1):1–8. doi: 10.1007/s00228-006-0206-z

Table 3.

Lewontin's D' and (r2) values in various populations

Population n UGT1A9
UGT2B7 UGT1A9-UGT2B7
8–98 8–766 98–766 211–802 8–211 8–802 98–211 98–802 766–211 766–802
CA 94 D' n.d. n.d. n.d. n.d. n.d. n.d. n.d. 1.00 n.d. n.d.
r2 (0.012)
AsA 83 D' 1.00 1.00 1.00 0.996 0.392 0.995 1.00 1.00 1.00 0.924
r2 (0) (0) (0) (0.068) (0.019) (0.017) (0.001) (0.004) (0.001) (0.008)
HA 87 D' n.d. n.d. n.d. 0.976 n.d. n.d. 1.00 0.992 n.d. n.d.
r2 (0.009) (0) (0.015)

n.d. not determined

HHS Vulnerability Disclosure